When people discuss counterintuitive policies on opioids and addiction, they often use the phrase, “follow the money”. We discuss the phrase’s meaning in detail, revealing the complex interplay of addiction medicine and healthcare economics.
To learn more about his work, please see the links below:
https://www.kapilnayar.com/ill-treatment
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
